National Health Investors, Inc. (NHI) Stock

About National Health Investors, Inc.

National Health Investors, Inc. (NHI) stock trades at $67.06 with a market capitalization of $3.29B. The stock is valued at a price-to-earnings (P/E) ratio of 18.94, price-to-book of 2.03, price-to-sales of 7.35. Over the past 52 weeks the stock has ranged between $63.81 and $91.38, and currently trades 26.6% below its 52-week high. It pays a dividend yielding 5.72%.

On profitability, National Health Investors, Inc. generates a return on equity (ROE) of 10.96%, return on capital employed of 8.11%, an operating margin of 51.45%, a net profit margin of 38.47%.

National Health Investors, Inc. by the numbers, 2016–2025

Between 2016 and 2025 National Health Investors, Inc. reported revenue of $249.0M rising to $379.0M, a change of +52.2% across 10 years. Compounded, revenue has grown 2.6% a year over five years, 10.9% over three, 13.1% over the last twelve months. Net profit fell to $142.0M.

Operating margin went from 71.5% in 2016 to 51.5% in 2025, a fall of 20.0 percentage points. The most recent net margin is 38.47%. On a trailing twelve-month basis to Jun '26, revenue is $434.0M and net profit $167.0M.

Borrowings held roughly flat from $1.1B to $1.2B, cash from operations was $240.0M in the latest year, positive in 10 of the last 10.

Return on equity has averaged 8.6% over five years, and was 9.3% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

National Health Investors, Inc. (NHI) — frequently asked questions